Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta()) in __number__ and atomoxetine (ATX, Strattera()) in __number__ , but data on the effect on drug usage patterns are scarce.